cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Supernus Pharmaceuticals Inc
12 own
18 watching
Current Price
$30.72
$0.04
(0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,598.15M
52-Week High
52-Week High
35.44000
52-Week Low
52-Week Low
21.99000
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.4016
iconMarket Capitalization1,598.15M
icon52-Week High35.44000
icon52-Week Low21.99000
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio21.4016
What does the Supernus Pharmaceuticals Inc do?
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
Read More
How much money does Supernus Pharmaceuticals Inc make?
News & Events about Supernus Pharmaceuticals Inc.
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Nov. 4, 2022 NEW YORK, Nov. 4...
Globe Newswire
1 year ago
NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (Supernus or the Company) (NASDAQ:SUPN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Oct. 26, 2022 NEW YORK, Oct. 26...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire NEW YORK, Oct. 19, 2022 NEW YORK, Oct. 19...
Globe Newswire
1 year ago
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (Supernus or the Company) (NASDAQ:SUPN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
Frequently Asked Questions
Frequently Asked Questions
What is Supernus Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Supernus Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Supernus Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Supernus Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Supernus Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Supernus Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Supernus Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Supernus Pharmaceuticals Inc?
plus_minus_icon
What percentage is Supernus Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Supernus Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$30.72
$0.04
(0.13%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Innoviva, Inc.
Innoviva, Inc.
$18.54
$0.35 (1.92 %)
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$36.07
$0.65 (1.84 %)
Prothena Corporation plc
Prothena Corporation plc
$24.43
$-0.36 (-1.45 %)
TG Therapeutics Inc
TG Therapeutics Inc
$20.57
$0.58 (2.93 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Innoviva, Inc.
Innoviva, Inc.
$18.54
$0.35 (1.92 %)
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$36.07
$0.65 (1.84 %)
Prothena Corporation plc
Prothena Corporation plc
$24.43
$-0.36 (-1.45 %)
TG Therapeutics Inc
TG Therapeutics Inc
$20.57
$0.58 (2.93 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00